President Trump on Friday signed four executive orders aimed at lowering drug prices, seeking to take action on a key issue for voters in an election year.
The orders signed by Trump would move towards allowing states to develop plans to import cheaper drugs from Canada, eliminate a system of drug discounts known as rebates in a bid to simplify the system, and seek to make EpiPens and insulin more affordable for patients of community health centers. It is unclear, though, when the moves can be finalized and take effect.
Trump also announced a fourth, more sweeping order, seeking to slash the price that Medicare pays for drugs to be in line with prices paid in other countries, what Trump called “most favored nation” status for the U.S.
Read more at The Hill.